LGALS3 and COVID-19: Using ROC analysis, a larger area under the curve (AUC) for the serum Galectin-3 level of the control group (AUC=0.622, 95% CI = 0.529-0.714; p=0.015) was calculated compared to the COVID-19 patient group for the diagnosis of COVID-19 disease.